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Purpose: The incremental diagnostic value of 18-fluorodeoxyglucose pos-
itron emission tomography (FDG-PET) and radiolabeled leukocyte scintig-
raphy (LS) has already been reported in infective endocarditis (IE) patients.
The aim of this study was to compare the respective performances of FDG-
PET and LS for the diagnosis of prosthetic valve (PVE)-IE in 39 patients.
Methods: FDG-PET and LS were performed in 39 consecutive patients
admitted for a clinical suspicion of PVE and inconclusive echocardiography
who underwent both FDG-PET and LS. FDG-PET and LS were analysed sep-
arately and retrospectively by experienced physicians blinded to the results of
the other imaging technique and to patient’s outcome. Final Duke-Li IE clas-
sification was performed after a 3-month follow-up period.
Results: Out of the 39 patients, 15 patients were classified after a 3-month
follow-up period as definite IE, 3 as possible IE and 21 as excluded IE.
Average time interval between FDG-PET and LS acquisitions was 7±7 days.
Sensitivity, specificity, positive predictive value, negative predictive value and
accuracy were 93%, 71%, 70%, 94% and 81% for FDG-PET and 60%, 100%,
100%, 78% and 83% for LS, respectively. Discrepancies between the results
of FDG-PET and LS occurred in 12 patients (31%). In patients with definite
IE, 5 were identified with true positive FDG-PET but false negative LS. Out
of these 5 patients, 3 presented non-pyogenic microorganism IE (Coxiella or
Candida). In patients with excluded endocarditis, 6 patients were identified
with true negative LS but false positive FDG-PET. These 6 patients had been
imaged in the first two months following the last cardiac surgery. 
Conclusions: FDG-PET offers a high sensitivity for the detection of active
infection in patients with a suspicion of PVE. LS offers a higher specificity
than FDG-PET for IE diagnosis and should be considered in case of inconclu-
sive FDG-PET findings or in the first two months after cardiac surgery.
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Introduction: Left atrial (LA) size has recently emerged as a prognostic
factor in patients with valvular heart disease. 
Aim of the study is to determine the utility of LA systolic function in
patients with aortic stenosis (AS)
Methods: we studied 178 patients (mean age 79.6±0.6 years) with severe
AS who underwent 2D echocardiography for the assessment of left ventricular
(LV) and right ventricular (RV) function, LA size, aortic valve morphology
and gradients. Peak LA strain (pLAS) measured by 2D speckle tracking echo-
cardiography (STE) was used to evaluate LA contractility. A pLAS ≤23% –
the indicated referral limit in normal population – was considered as an index
of impaired LA contractility. 
Results: A pLAS ≤23% was very common in patients with AS (n=139,
79%). Patients with reduced pLAS had greater LA volume (52.9±15.7 vs
36.6±7.8ml/m², p<0.0001), reduced LV ejection fraction (54.2±12.8 vs
61.5±7.7%, p=0.001), reduced TAPSE (19.9±4.3 vs 22.3±4.0mm, p=0.003), a
more severe aortic stenosis (aortic surface: 0.40±0.09 vs 0.48±0.13 cm²/m²,
p<0.0001) and higher lnNT-proBNP (7.6±1.3 vs 6.1±1.4, p<0.0001) levels. The
main factors associated with pLAS were: left ventricular global longitudinal
strain, lnNT-proBNP, indexed LA volume, and TAPSE (β=–0.58, – 0.56, – 0.51
and – 0.43 respectively; all p<0.0001). At Kaplan-Meyer analysis, a reduced
pLAS was associated with increased all cause mortality and major adverse car-
diovascular events (MACEs) (Log Rank test p=0.05 and P=0.008 respectively). 
Conclusions: in patients with AS, LA systolic dysfunction is very common
and is associated with LA dilatation and biventricular impairment. A reduced
survival and a significantly higher recurrence of MACEs were also observed in
these population. Further studies, exploring LA relaxation and overall dynamics
are necessary to support the utility of quantitative echocardiographic assessment
of LA function as an additional tool to guide management of patients with AS. 
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Background: Secondary mitral regurgitation (MR) is a serious and fre-
quent complication of dilated cardiomyopathy and/or coronary artery disease.
The impact of exerxise pulmonary hypertension (ExPHT) on outcome in
patients with secondary MR is unknown.
Method and results: All patients with secondary MR, sinus rhythms,
narrow QRS (<120ms) and referred for exercise stress echocardiography with
quantifiable exercise systolic pulmonary arterial pressure (SPAP), were included
in this study (n=159, 65±11 years, 66% of male). Resting and ExPHT were
defined as a systolic pulmonary arterial pressure (SPAP) >50mmHg and
>60mmHg, respectively. ExPHT was more frequent than resting PHT (40% vs.
13%, p<0.0001). There was no significant difference between patients with or
without ExPHT regarding demographic and clinical data, as well as medication.
Using multiple linear regression, exercise SPAP was determined by resting
SPAP (β=0.94±0.1, p<0.0001), exercise MR severity (β=0.58±0.1, p<0.0001),
and resting e'-wave velocity (β=–1.3±0.4, p=0.004). During a mean follow-up
of 35±11 months, 60 major adverse cardiovascular events occured. The inci-
dence of combined cardiac event was significantly higher in patients with
ExPHT as compared to those without ExPHT (2-year: 11±3 vs. 28±6%; 4-year:
20±5 vs. 40±7%, p<0.0001). Similarly, patients with ExPHT demonstrated signi-
ficantly reduced survival (2-year: 88±4 vs. 99±1%; 4-year: 62±8% vs. 94±2%,
p<0.0001). In multivariate Cox proportional Hazard model, after adjustment for
age, sex, left ventricular volumes, both resting and exercise diastolic function
and resting MR severity, ExPHT remains significantly associated with high risk
of combined cardiac event (Hazard ratio=3.7, 95% of CI: 1.9-7.2, p<0.0001).
Conclusion: In patients with secondary MR, ExPHT may be frequent and
mainly determined by resting SPAP, LV diastolic burden markers and exercise
MR severity. ExPHT is a powerful predictor of poor outcome and is associ-
ated with a 3.7-fold increase in risk of cardiac event. These results further
highlight the usefulness of exercise stress echocardiography for the manage-
ment and the risk stratification of these patients. 
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Background: The global left ventricular (LV) hemodynamic afterload as
assessed by valvulo arterial impedance (Zva), may be an independent pre-
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